Amneal Pharmaceuticals LLC.

In News

Amneal to Report Third Quarter 2026 Results on November 3, 2026 - GlobeNewswire

GlobeNewswire - Oct 08, 2026

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution - Yahoo Finance

Yahoo Finance - Jun 04, 2026

Kaskela Law LLC Announces Investigation of Amneal Pharmaceuticals, Inc. (AMRX) and Encourages AMRX Shareholders to Contact the Firm - Business Wire

Business Wire - Jul 23, 2026

Amneal Sues Alembic to Block Copies of Crexont Parkinson’s Drug - Bloomberg Law News

Bloomberg Law News - Jul 06, 2026

Amneal recalls one lot of IV magnesium after IV tranexamic acid mix-up - Springer Nature Link

Springer Nature Link - Apr 04, 2026

Amneal closes $1.1B Kashiv Biosciences acquisition - NJBIZ

NJBIZ - Aug 11, 2026

Amneal Pharmaceuticals purchases New Jersey plant - Reliable Plant

Reliable Plant - Jan 03, 2026

Amneal Pharmaceuticals acquires Kashiv BioSciences for up to $1.1 billion - PharmaLive

PharmaLive - Apr 22, 2026

Macleods, Amneal Recall Olanzapine, Exenatide Products in US Over Quality Issues - Medical Dialogues

Medical Dialogues - Oct 02, 2026

Amneal Announces FDA Approval and Launch of Lanreotide Injection - GlobeNewswire

GlobeNewswire - Sep 18, 2026

Mix-up forces national recall of magnesium sulfate bags - 104.5 WOKV

104.5 WOKV - Mar 25, 2026

Kashiv BioSciences Agrees to Be Acquired by Amneal Pharmaceuticals to Create a Fully Integrated Global Biosimilar Leader - Business Wire

Business Wire - Apr 22, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment